印度的醫藥品物流市場:類別，次序，各零件，各用途，運用，各地區，機會，預測，2019年～2033年

印度醫藥物流市場規模預計將從2025年的39.3億美元成長到2033年的73.4億美元，複合年增長率為8.12%。印度物流公司正透過投資冷藏卡車、GPS監控貨櫃、數據記錄器以及與製藥商合作等方式進行調整。印度醫藥物流市場不僅在不斷發展，還在合規性、冷鏈擴展和最後一英里完整性方面進行重新調整。由於印度是全球最大的仿製藥供應國，也是疫苗的主要供應國，因此對醫藥級物流的期望比以往任何時候都高。隨著需求（尤其是生物製藥和特種藥品的需求）不斷增長，傳統的 "倉儲到配送" 模式正在演變為一個多層次的生態系統，具備溫度監控、數位追蹤和即時可視性。

此外，醫藥供應鏈正變得更加以病人為中心。電子藥局、對溫度敏感的原料藥 (API) 以及個人化醫療的興起，帶來了新的複雜層面，對高服務水準、快速交付和嚴格的處理規程提出了更高的要求。諸如 "總理加蒂·沙克蒂" 計劃和修訂後的中央藥品標準控制組織 (CDSCO) 指南等政府舉措改善了多層次的運輸連通性，並協調了倉儲和運輸條件。此外，印度的醫藥市場正在經歷巨大的成長。例如，根據聯合國人口基金 (UNFPA) 的估計，到 2050 年，印度預計將有約 3.47 億人年齡在 60 歲或以上。由於老年人更容易患病，這將進一步增加對藥品的需求，預計這將推動印度醫藥物流市場的發展。

本報告提供印度的醫藥品物流市場相關調查，市場概要，以及類別，次序，各零件，各用途，運用，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 美國的關稅的影響

第4章 摘要整理

第5章 顧客的迴響

第6章 印度的醫藥品物流市場預測，2019年～2033年

• 市場規模分析與預測
• 市場佔有率分析與預測
  • 類別
    • 低溫運輸物流
    • 非低溫運輸物流
  • 按次序
    • 揀貨
    • 儲存
    • 搜索系統
    • 處理系統
  • 各零件
    • 保管
    • 運輸
    • 零組件的監測
  • 各用途
    • 化學藥品
    • 生物醫藥品
    • 專門醫藥品
  • 按運用
    • 海路
    • 道路
    • 鐵路
    • 航空
    • 儲存和服務
  • 各地區
    • 北部
    • 東部
    • 西部和中央部
    • 南部
  • 各企業市場佔有率分析(前五名公司以及其他- 以金額為準，2025年)
• 2025年的市場地圖分析

第7章 需求供給分析

第8章 價值鏈分析

第9章 波特的五力分析

第10章 大環境分析

第11章 服務價格分析

第12章 市場動態

• 市場促進因素
• 市場課題

第13章 消費者購買行為分析

第14章 市場趨勢與發展

第15章 政策和法規情形

第16章 案例研究

第17章 競爭情形

• 前五名市場領導的競爭矩陣
• 前五名參與企業的SWOT分析
• 前10名市場主要企業的形勢
  • Allcargo Logistics Ltd.
  • Safexpress Pvt. Ltd.
  • Mahindra Logistics Limited
  • AWL India Private Limited
  • Snowman Logistics Pvt Ltd
  • EasyWay Logistics Pvt Ltd
  • Stellar Value Chain Solutions Pvt Ltd
  • Future Supply Chain Solutions Ltd.
  • Varuna Group
  • TCI Express Ltd.

第18章 策略性建議

第19章 關於調查公司·免責聲明

Indian pharmaceutical logistics market is projected to witness a CAGR of 8.12% during the forecast period, FY2026-FY2033, growing from USD 3.93 billion in FY2025 to USD 7.34 billion in FY2033, driven by surging exports, rising domestic consumption, and increased regulatory scrutiny. India's logistics players are adapting through investments in reefer trucks, GPS-monitored containers, data loggers, and partnerships with pharmaceutical manufacturers. India's pharmaceutical logistics market is not just evolving, it is recalibrating around compliance, cold chain expansion, and last-mile integrity. With India being the world's largest provider of generic medicines and a critical supplier of vaccines, the stakes for pharma-grade logistics have never been higher. The traditional warehousing-to-distribution model has evolved into a multi-tiered ecosystem driven by temperature monitoring, digital tracking, and real-time visibility, particularly with the rising demand for biopharma and specialty drugs.

Moreover, the pharma supply chain is becoming more patient-centric. The growth of e-pharmacies, temperature-sensitive APIs, and personalized medicine has introduced a new complexity layer, demanding high service levels, rapid fulfillment, and strict handling protocols. Government initiatives such as the PM Gati Shakti programme and revised guidelines under CDSCO (Central Drugs Standard Control Organization) are improving multimodal connectivity and harmonizing storage and transit conditions. Additionally, the Indian pharmaceutical market is growing enormously. For instance, as per the estimates of the United Nations Population Fund (UNFPA), approximately 347 million individuals in India are expected to be sixty or older by 2050. This is further expected to boost the requirement for pharmaceuticals as the elderly are more susceptible to diseases, driving the India pharmaceutical logistics market.

Market Growth due to Surge in Cold Chain Demand Due to Biopharma and Specialty Drugs

Cold chain logistics is no longer a niche in India; it is becoming the standard for high-value pharmaceutical movement. Biologics, vaccines, insulin, and advanced therapies require a tightly controlled cold chain infrastructure, from production to the patient.

In September 2023, India's Ministry of Health & Family Welfare issued new draft norms requiring mandatory validation of cold storage facilities for vaccine and insulin supply chains, both for public and private sector logistics players. This has led to a significant private sector response. In January 2024, Snowman Logistics inaugurated a new pharma-grade cold storage facility in the Northeast in January 2024, adding around 5,000 pallets of 2-8°C storage, specifically catering to vaccine and biologics clients in western India.

The rising demand from clinical trials and the growing portfolio of India's biopharma exports, including mRNA and biosimilars, are also pushing 3PLs to upgrade infrastructure. Gati Kausar and ColdEx have both announced fleet expansion plans for pharma-grade reefer trucks with continuous temperature monitoring. Cold chain is no longer an optional add-on; it is a competitive mandate.

Multimodal Logistics Expansion and Policy Support Leading to an Increase in Market Reach

Logistics players are finally moving beyond just roads. India's multimodal push, especially under PM Gati Shakti, is reconfiguring pharma logistics routes for better time-cost efficiency. Rail and air freight are gaining traction for high-value, low-volume drugs that need speed and precision.

In February 2024, the Indian Railways launched Pharma Express, a dedicated temperature-controlled freight service between Hyderabad and Delhi, with pre-booked reefer containers and validated SOPs in partnership with logistics players such as TCI Express Limited and Allcargo Logistics Limited.

Meanwhile, air cargo terminals in Delhi, Mumbai, and Hyderabad have seen capacity upgrades, including pharma corridors with end-to-end cold chain monitoring, coordinated by the Air Cargo Forum India (ACFI) and AAI Cargo Logistics & Allied Services (AAICLAS).

The growing export of bulk drugs, APIs, and high-value generics, particularly to the U.S. and Europe, is making multimodal logistics not just viable but essential. Add to this, policy-level clarity around standardization, and logistics firms now have an environment conducive to infrastructure scaling.

Dominance of Biopharma Application in Logistics Spend

Among all pharmaceutical verticals, biopharma commands the highest logistics complexity and spend, making it the dominant segment in India's pharmaceutical logistics landscape. Biopharmaceuticals have stringent temperature requirements (2-8 degrees Celsius or even 20 degrees Celsius for some mAbs), short shelf lives, and often involve bulk movement to centralized cold chain hubs for global distribution. With India emerging as a preferred CDMO (Contract Development and Manufacturing Organization) partner for global biologics, logistics has taken center stage.

In July 2023, Biocon Biologics expanded its export footprint by shipping biosimilars from its Bengaluru site to 70 countries, supported by partnerships with Stellar Value Chain Solutions for packaging, conditioning, and validated route mapping.

Biopharma also includes temperature-sensitive clinical trial logistics - an area that has grown as India becomes a testbed for global Phase II/III studies. Logistics providers catering to this segment are adding passive containers, validated SOPs, and a GDP-trained workforce to maintain regulatory compliance. This sub-sector's precision demands are setting new industry benchmarks and commanding premium pricing in logistics contracts.

Impact of U.S. Tariffs on India Pharmaceutical Logistics Market

U.S. tariffs on pharmaceuticals on Indian goods and pharma products will disrupt India's pharmaceutical exports, and the pharma supply chain will largely impact "exports" & "cost to the supply chain." Specifically, the U.S. can impose higher tariffs on drugs or APIs manufactured in India. Increased pharmaceutical logistics providers may face the following issues: Reduced export, increased warehousing diversification in other markets such as Africa, Europe, and Latin America, exponentially high input costs: Raw materials are expensive or increase prices, e.g., tariffs on "Chinese intermediates used in Indian pharma." Increases warehousing and transportation costs, such as the cold chain, which is more expensive.

Key Players Landscape and Outlook

India's pharmaceutical logistics market is relatively fragmented, but clear leaders are emerging based on service specialization, cold chain depth, and multimodal adaptability. Snowman Logistics, Gati Kausar, and ColdEx lead the cold chain space with pharma-grade warehouses and reefer fleets. Stellar Value Chain and TCI Express are strong in multi-zone transport and compliance-driven packaging solutions. Many players are integrating real-time visibility platforms, investing in blockchain-based tracking, and training the workforce under WHO-GDP guidelines. Mahindra Logistics Limited and Reefer Express, though smaller, have carved out niches in intra-state biopharma supply. What differentiates players now is not just delivery timelines, but how well they can comply, monitor, and adapt in an increasingly regulated and digitized ecosystem.

In December 2023, the boards of Allcargo Logistics Limited and Allcargo Gati Limited approved a composite scheme of arrangement to restructure their businesses. Under the plan, the International Supply Chain (ISC) business-including both the India operations and international subsidiaries-demerged into a new entity, Allcargo ECU Limited. The remaining express and contract logistics businesses were consolidated under Allcargo Logistics. This restructuring aimed to simplify the corporate structure, enhance synergies, and provide direct shareholding to Allcargo and Allcargo Gati shareholders.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Voice of Customers

• 5.1. Regulatory Compliance
• 5.2. Quality Management and Traceability
• 5.3. Industry Experience and Reputation
• 5.4. Customer Service and Support

6. India Pharmaceutical Logistics Market Outlook, FY2019-FY2033F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Type
    • 6.2.1.1. Cold Chain Logistics
    • 6.2.1.2. Non-Cold Chain Logistics
  • 6.2.2. By Procedure
    • 6.2.2.1. Picking
    • 6.2.2.2. Storage
    • 6.2.2.3. Retrieval Systems
    • 6.2.2.4. Handling Systems
  • 6.2.3. By Component
    • 6.2.3.1. Storage
    • 6.2.3.2. Transportation
    • 6.2.3.3. Monitoring Components
  • 6.2.4. By Application
    • 6.2.4.1. Chemical Pharma
    • 6.2.4.2. Biopharma
    • 6.2.4.3. Specialized Pharma
  • 6.2.5. By Operation
    • 6.2.5.1. Seaways
    • 6.2.5.2. Roadways
    • 6.2.5.3. Railways
    • 6.2.5.4. Airways
    • 6.2.5.5. Storage and Services
  • 6.2.6. By Region
    • 6.2.6.1. North
    • 6.2.6.2. East
    • 6.2.6.3. West and Central
    • 6.2.6.4. South
  • 6.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2025)
• 6.3. Market Map Analysis, FY2025
  • 6.3.1. By Type
  • 6.3.2. By Procedure
  • 6.3.3. By Component
  • 6.3.4. By Application
  • 6.3.5. By Operation
  • 6.3.6. By Region

7. Demand Supply Analysis

8. Value Chain Analysis

9. Porter's Five Forces Analysis

10. PESTLE Analysis

11. Service Pricing Analysis

12. Market Dynamics

• 12.1. Market Drivers
• 12.2. Market Challenges

13. Consumer Buying Behavior Analysis

14. Market Trends and Developments

15. Policy and Regulatory Landscape

16. Case Studies

17. Competitive Landscape

• 17.1. Competition Matrix of Top 5 Market Leaders
• 17.2. SWOT Analysis for Top 5 Players
• 17.3. Key Players Landscape for Top 10 Market Players
  • 17.3.1. Allcargo Logistics Ltd.
    • 17.3.1.1. Company Details
    • 17.3.1.2. Key Management Personnel
    • 17.3.1.3. Products and Services
    • 17.3.1.4. Financials (As Reported)
    • 17.3.1.5. Key Market Focus and Geographical Presence
    • 17.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 17.3.2. Safexpress Pvt. Ltd.
  • 17.3.3. Mahindra Logistics Limited
  • 17.3.4. AWL India Private Limited
  • 17.3.5. Snowman Logistics Pvt Ltd
  • 17.3.6. EasyWay Logistics Pvt Ltd
  • 17.3.7. Stellar Value Chain Solutions Pvt Ltd
  • 17.3.8. Future Supply Chain Solutions Ltd.
  • 17.3.9. Varuna Group
  • 17.3.10. TCI Express Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

18. Strategic Recommendations

19. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Pharmaceutical Logistics Market, By Value, In USD Billion, FY2019-FY2033F
• Figure 2. India Pharmaceutical Logistics Market Share (%), By Type, FY2019-FY2033F
• Figure 3. India Pharmaceutical Logistics Market Share (%), By Procedure, FY2019-FY2033F
• Figure 4. India Pharmaceutical Logistics Market Share (%), By Component, FY2019-FY2033F
• Figure 5. India Pharmaceutical Logistics Market Share (%), By Application, FY2019-FY2033F
• Figure 6. India Pharmaceutical Logistics Market Share (%), By Operation, FY2019-FY2033F
• Figure 7. India Pharmaceutical Logistics Market Share (%), By Region, FY2019-FY2033F
• Figure 8. By Type Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 9. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 10. By Component Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 11. By Application Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 12. By Operation Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 13. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2025